<DrugInformationSummary id="CDR0000787676"><DrugInfoMetaData><DrugInfoType>Brief</DrugInfoType><DrugInfoAudience>Patients</DrugInfoAudience><DrugInfoDescription>Ribociclib succinate works by blocking the activity of proteins called CDK4 and CDK6 that control how fast cells grow. Blocking these proteins may slow or stop the growth of cancer cells. Ribociclib succinate is a type of targeted therapy drug called a kinase inhibitor. It is a small-molecule drug (a drug that can enter cells easily).</DrugInfoDescription><DrugInfoURL xref="https://www.cancer.gov/about-cancer/treatment/drugs/ribociclib">Ribociclib</DrugInfoURL><FDAApproved>Yes</FDAApproved><TerminologyLink ref="CDR0000689330">ribociclib succinate</TerminologyLink><GlossaryLink ref="CDR0000787678">ribociclib succinate</GlossaryLink><USBrandNames><USBrandName>Kisqali</USBrandName></USBrandNames><PronunciationInfo><TermPronunciation>RY-boh-SY-klib SUK-sih-nayt</TermPronunciation><MediaLink ref="CDR0000788409" type="audio/mpeg" alt="" language="en" id="_5"/><MediaLink ref="CDR0000788408" type="audio/mpeg" alt="" language="es" id="_6"/></PronunciationInfo><FDAExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aaeaef94-f3f5-4367-8ea2-b181d7be2da8&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</FDAExternalRef></DrugInfoMetaData><DrugInfoTitle>Ribociclib Succinate</DrugInfoTitle><Section id="_FDA"><Para><ExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aaeaef94-f3f5-4367-8ea2-b181d7be2da8&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</ExternalRef></Para></Section><Section id="_1"><Title>Use in Cancer</Title>                                                              
  <Para id="_2">Ribociclib succinate is approved to be used with other drugs to treat:</Para>                          
  <ItemizedList Style="bullet" id="_3">
   <ListItem><Strong><GlossaryTermRef href="CDR0000444971" dictionary="Cancer.gov" audience="Patient">breast cancer</GlossaryTermRef></Strong> that is <GlossaryTermRef href="CDR0000788029" dictionary="Cancer.gov" audience="Patient">hormone receptor positive</GlossaryTermRef> (HR+) and <GlossaryTermRef href="CDR0000774531" dictionary="Cancer.gov" audience="Patient">HER2 negative</GlossaryTermRef> (HER2-). It is used:<ItemizedList Style="bullet" id="_5"><ListItem>with an <GlossaryTermRef href="CDR0000044232" dictionary="Cancer.gov" audience="Patient">aromatase inhibitor</GlossaryTermRef> in women who have stage II or stage III <GlossaryTermRef href="CDR0000446564" dictionary="Cancer.gov" audience="Patient">early breast cancer</GlossaryTermRef> that is at high risk of coming back</ListItem><ListItem>with an <GlossaryTermRef href="CDR0000044232" dictionary="Cancer.gov" audience="Patient">aromatase inhibitor</GlossaryTermRef> in women whose cancer has spread and has not been treated with <GlossaryTermRef href="CDR0000045110" dictionary="Cancer.gov" audience="Patient">hormone therapy</GlossaryTermRef></ListItem><ListItem>with <GlossaryTermRef href="CDR0000306498" dictionary="Cancer.gov" audience="Patient">fulvestrant</GlossaryTermRef> in women whose cancer has spread and has not been treated with hormone therapy or whose cancer got worse during treatment with hormone therapy</ListItem></ItemizedList></ListItem>
   </ItemizedList>
  <Para id="_6">Ribociclib succinate is also available in a combination pack with <GlossaryTermRef href="CDR0000045421" dictionary="Cancer.gov" audience="Patient">letrozole</GlossaryTermRef>.  Ribociclib succinate and letrozole may work better together than when either is given alone. For more information that may apply to this combination pack, see the Drug Information Summary for <DrugRef href="CDR0000816806" url="/about-cancer/treatment/drugs/ribociclib-succinate-and-letrozole">Ribociclib Succinate and Letrozole</DrugRef>.</Para><Para id="_4">Ribociclib
         succinate is also being studied in the treatment of other types of
         cancer.</Para>
 </Section><Section id="_About"><Title>More About Ribociclib Succinate</Title><Para id="_Dict_1"><ExternalRef xref="https://www.cancer.gov/publications/dictionaries/cancer-drug/def/689330">Definition from the NCI Drug Dictionary</ExternalRef> - Detailed scientific definition and other names for this drug.</Para>

<Para id="_About_8.39">MedlinePlus Information on <ExternalRef xref="https://medlineplus.gov/druginfo/meds/a617008.html">Ribociclib Succinate</ExternalRef> - A lay language summary of important information about this drug that may include the following:</Para>
<ItemizedList Style="bullet" id="_About_9.40"><ListItem>warnings about this drug,</ListItem><ListItem>what this drug is used for and how it is used,</ListItem><ListItem>what you should tell your doctor before using this drug,</ListItem><ListItem>what you should know about this drug before using it, </ListItem><ListItem>other drugs that may interact with this drug, and</ListItem><ListItem>possible side effects.  </ListItem></ItemizedList><Para id="_About_10.41">Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for.  This patient information sheet applies only to approved uses of the drug.  However, much of the information may also apply to unapproved uses that are being studied.</Para></Section><Section id="_Research"><Title>Research Results and Related Resources</Title><Para><ExternalRef xref="https://www.cancer.gov/news-events/cancer-currents-blog/2023/kisqali-hormone-therapy-breast-cancer">A Safer, Better Treatment Option for Some Younger Women with Breast Cancer</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies">Targeted Therapy to Treat Cancer</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/news-events/cancer-currents-blog/2021/ribociclib-improves-metastatic-breast-cancer-survival">Combo of Ribociclib, Letrozole Improves Survival in Advanced Breast Cancer</ExternalRef></Para></Section><Section id="_ClinicalTrial_1"><Title>Clinical Trials Accepting Patients</Title><Para id="_ClinicalTrial_2"><ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials/intervention/C152210">Find Clinical Trials for Ribociclib Succinate</ExternalRef> - Check for trials from NCI's list of cancer clinical trials now accepting patients.</Para></Section> 
  <DrugInfoDisclaimer>


<Para id="_Disclaimer_4"><Strong>Important: </Strong>The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
</Para></DrugInfoDisclaimer> 
  <DateFirstPublished>2017-03-16</DateFirstPublished><DateLastModified>2024-12-23</DateLastModified></DrugInformationSummary>
